This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Mettler-Toledo International Inc. (MTD): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Mettler-Toledo International (MTD) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.1%. By the end of trading, Mettler-Toledo International rose $2.22 (1.4%) to $164.98 on average volume. Throughout the day, 204,363 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 246,400 shares. The stock ranged in a price between $162.99-$166.62 after having opened the day at $163.65 as compared to the previous trading day's close of $162.76. Other companies within the Health Services industry that increased today were: Response Genetics (RGDX), up 14.3%, Tengion (TNGN), up 13%, Kips Bay Medical (KIPS), up 7.2%, and Invacare Corporation (IVC), up 6.5%.

Mettler-Toledo International Inc. engages in the research, development, manufacture, and marketing of precision instruments and software primarily in Europe, North and South America, and Asia. Mettler-Toledo International has a market cap of $5.23 billion and is part of the health care sector. The company has a P/E ratio of 19.2, below the average health services industry P/E ratio of 19.7 and above the S&P 500 P/E ratio of 17.7. Shares are up 10.9% year to date as of the close of trading on Monday. Currently there are four analysts that rate Mettler-Toledo International a buy, one analyst rates it a sell, and five rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, notable return on equity and increase in stock price during the past year. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front, ImmunoCellular Therapeutics (IMUC), down 16.5%, Graymark Healthcare (GRMH), down 7.6%, AtriCure (ATRC), down 5.9%, and Unilife Corporation (UNIS), down 5.6%, were all laggards within the health services industry with DaVita (DVA) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR (XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care (RXD).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Submit an article to us!
DOW 17,042.06 +62.93 0.37%
S&P 500 1,991.46 +4.95 0.25%
NASDAQ 4,526.3190 -0.1630 -0.00%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs